Well Care Compounding Pharmacy recalls

Well Care Compounding Pharmacy has 51 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 15 Jun 2016. The most frequent reason is sterility.

Total recalls51since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 15 Jun 2016

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 51 100%Class III 0 0%

Why well care compounding pharmacy is recalled

Sterility51100%

Product types

By year

201651100%

All well care compounding pharmacy recalls, newest first

51 total

Reported	Class	Recall	Company	Reason	Where
15 Jun 2016Drug	CLASS II	Atropine Sulfate 5% Ophthalmic Drops recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	M.i.c. /mb12/b6/dexplan/l-carn, 25mg/50mg/25mg/10mg/10mg/ML recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Estradiol Valerate 20mg/ML recalled by Well Care Compounding Pharmacy	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Tri-mix # 5, packaged in 5 mL vials, Rx only, Well Care Compounding recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Testosterone Cypionate 10mg/ML recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Testosterone Cypionate 100mg/ML recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Testosterone Cypionate 150mg/ML recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Testosterone Cypionate 200mg/ML recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Tri-mix # 3, packaged in 5mL vials, Rx only, Well Care Compounding recalled	Well Care Compounding Pharmacy	Sterility	NV
15 Jun 2016Drug	CLASS II	Testosterone Cypionate 175mg/ML recalled	Well Care Compounding Pharmacy	Sterility	NV

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.